The world moves. We make sense of it.

Funding Details

Deyi Medical completed its extended Series A funding round on October 16, raising tens of millions of yuan, as reported by Dealroom (Deyi Medical pozyskuje finansowanie od Chlitina na rozwój robotów medycznych AI). Chlitina, an international health and beauty network, served as the sole strategic investor (Deyi Medical pozyskuje finansowanie od Chlitina na rozwój robotów medycznych AI).

Technology Focus

The capital will support the development of artificial intelligence medical robots designed for physiotherapy and rehabilitation applications, according to Dealroom (Deyi Medical pozyskuje finansowanie od Chlitina na rozwój robotów medycznych AI). AI-driven rehabilitation technology aims to improve precision and personalization in physical therapy, addressing growing demand for automated medical solutions in China's healthcare system.

Company Background

Deyi Medical operates as a Chinese startup in the medical technology sector, focusing on integrating AI into therapeutic and recovery devices, Dealroom reports (Deyi Medical pozyskuje finansowanie od Chlitina na rozwój robotów medycznych AI). The company targets the rehabilitation market, where robotic assistance can enhance treatment outcomes and reduce manual workload for healthcare providers.

Strategic Partnership

Chlitina's exclusive investment represents cross-industry collaboration between health, beauty, and medical technology sectors, according to Dealroom (Deyi Medical pozyskuje finansowanie od Chlitina na rozwój robotów medycznych AI). The partnership is intended to accelerate innovation and market entry for Deyi Medical's robotic solutions (Deyi Medical pozyskuje finansowanie od Chlitina na rozwój robotów medycznych AI).

Źródła

• Deyi Medical pozyskuje finansowanie od Chlitina na rozwój robotów medycznych AI